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In the original version of this article, we described a function for the single Toll-like receptor in the nematode C. ele-
gans. In this study we also reported the characterization of a gene similar to the kinase IRAK, pik-1 and failed to show
any significant phenotype for a mutant pik-1 strain. We subsequently determined that the strain supposed to be a
homozygous pik-1(nr2019) mutant does not contain the predicted deletion. A new pik-1 allele (tm2167) produced by
the Japanese National Bioresource Project was kindly provided by the project’s coordinator, S. Mitani. This mutant
behaved in a very similar manner to the original strain. Thus pik-1(tm2167) mutants showed no visible phenotype,
no alteration in the swelling phenotype to Microbacterium nematophilum (J. Hodgkin, personal communication),
a wild-type resistance to Pseudomonas aeruginosa strain PA14, and a slightly decreased longevity both on Serratia
marcescens and Escherichia coli strain OP50. Given these results, our original conclusions regarding pik-1 are
unchanged. Clearly, all further observations and conclusions in the paper are not affected by this revision. We thank
Oliver Zugasti for performing survival assays and Jonathan Hodgkin for communicating unpublished results.DOI: 10.1016/j.cub.2006.07.019
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